Submissions on this consultation have now closed.
The Therapeutic Products Bill would replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. This includes medicines (including cell and tissue products) and medical devices. Natural Health Products (including rongoā Māori) will be excluded, as far as possible, as the Government is considering options for how these could be regulated as a separate process.
As part of the development of the Therapeutic Products Bill, the Ministry of Health consulted on a draft of the Bill from December 2018 to April 2019.
Accompanying the Bill was the Therapeutic Products Regulatory Scheme: Consultation document. The purpose of this consultation document was to help stakeholders understand the draft Therapeutic Products Bill and to seek feedback on the provisions, and key policy matters, in the Bill.
Consultation closed on 18 April. We would like to thank the stakeholders who made a submission on the Bill.
Ministry officials will analyse the feedback received, provide advice to the Government on the overall outcomes of the consultation and seek approval for any major changes in policy identified. We will then work with the Parliamentary Counsel Office to amend the Bill, as necessary, before it enters the parliamentary process. We expected there will be further consultation as part of the parliament process.